Condition
Stargardt clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Stargardt clinical trials that are recruiting, at sites in 4 countries (most in China (1), Germany (1), United Kingdom (1)). By phase: Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 4Countries
All recruiting trials (2)
-
ZVS106e subretinal injection for Stargardt disease from two ABCA4 mutations
This treatment will try a single subretinal injection of ZVS106e in one eye to see if it's safe and may help people aged 8 and older with Stargardt disease caused by two ABCA4 mutations.
-
Observing the progression of Stargardt Disease Type 1
This study is tracking how Stargardt Disease Type 1 progresses in about 75 people to better understand the condition and help improve future treatments.
Related topics
Quick answers
How many Stargardt clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in China (1 trial), Germany (1 trial), United Kingdom (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.